The Potential Benefit of Complementary/Alternative Medicine in

315 Pages·2012·34.32 MB·English

Evidence-Based Complementary and Alternative Medicine
The Potential Benefit of
Complementary/Alternative
Medicine in Cardiovascular
Diseases
Guest Editors: Ke-ji Chen, Ka Kit Hui, Myeong Soo Lee, and Hao Xu
The Potential Benefit of Complementary/
Alternative Medicine in Cardiovascular
Diseases
Evidence-Based Complementary and Alternative Medicine
The Potential Benefit of Complementary/
Alternative Medicine in Cardiovascular
Diseases
Guest Editors: Ke-ji Chen, Ka Kit Hui, Myeong Soo Lee,
and Hao Xu
Copyright©2012HindawiPublishingCorporation.Allrightsreserved.
Thisisaspecialissuepublishedin“Evidence-BasedComplementaryandAlternativeMedicine.”Allarticlesareopenaccessarticles
distributedundertheCreativeCommonsAttributionLicense,whichpermitsunrestricteduse,distribution,andreproductioninany
medium,providedtheoriginalworkisproperlycited.
Editorial Board
ShrikantAnant,USA YounChulKim,RepublicofKorea CesarR.Ramos-Remus,Mexico
VassyaBankova,Bulgaria YoshiyukiKimura,Japan KeRen,USA
WinfriedBanzer,Germany ToshiakiKogure,Japan Jose´ LuisR´ıos,Spain
VernonBarnes,USA AlfredLa¨ngler,Germany PaoloRobertidiSarsina,Italy
DebraL.Barton,USA LixingLao,USA BasharSaad,PalestinianAuthority
JairoKenuppBastos,Brazil Jang-HernLee,RepublicofKorea AndreasSandner-Kiesling,Austria
DavidBaxter,NewZealand MyeongSooLee,RepublicofKorea AdairRobertoSoaresSantos,Brazil
AlvinJ.Beitz,USA TatleangLee,Singapore G.Schmeda-Hirschmann,Chile
PaoloBellavite,Italy ChristianLehmann,Canada AndrewScholey,Australia
FrancescaBorrelli,Italy Ping-ChungLeung,HongKong DanaSeidlova-Wuttke,Germany
ArndtBu¨ssing,Germany Xiu-MinLi,USA SenthamilR.Selvan,USA
LeighF.Callahan,USA ChunGuangLi,Australia RonaldSherman,USA
RaffaeleCapasso,Italy SabinaLim,RepublicofKorea KanShimpo,Japan
Il-MooChang,RepublicofKorea GerhardLitscher,Austria VenilN.Sumantran,India
YunfeiChen,China I-MinLiu,Taiwan TakashiTakahashi,Japan
KevinW.Chen,USA KeLiu,ChinaIre´neLund,Sweden TokuTakahashi,USA
Juei-TangCheng,Taiwan GailMahady,USA JoannaThompson-Coon,UK
Jen-HweyChiu,Taiwan FrancescoMarotta,Italy MeiTian,USA
JaeYoulCho,RepublicofKorea VirginiaS.Martino,Argentina K.V.Trinh,Canada
WilliamC.Cho,HongKong JamesH.McAuley,Australia AlfredoVannacci,Italy
Shuang-EnChuang,Taiwan AndreasMichalsen,Germany SørenVentegodt,Denmark
EdwinL.Cooper,USA DavidMischoulon,USA CarloVentura,Italy
VincenzoDeFeo,Italy MarkA.Moyad,USA WagnerVilegas,Brazil
AlexandraDeters,Germany StephenMyers,Australia PradeepVisen,Canada
NobuakiEgashira,Japan S.Nagini,India AristoVojdani,USA
PeterFisher,UK VitalyNapadow,USA DietlindWahner-Roedler,USA
JoelJ.Gagnier,Canada IsabellaNeri,Italy Shu-MingWang,USA
MichaelGoldstein,USA MartinOffenbacher,Germany KenjiWatanabe,Japan
S.-H.Hong,RepublicofKorea Ki-WanOh,RepublicofKorea WolfgangWeidenhammer,Germany
MarkusHorneber,Germany Y.Ohta,Japan JennyM.Wilkinson,Australia
ChingLiangHsieh,Taiwan OlumayokunA.Olajide,UK HarukiYamada,Japan
BennyTanKwongHuat,Singapore ThomasOstermann,Germany NobuoYamaguchi,Japan
RomanHuber,Germany BhushanPatwardhan,India HitoshiYamashita,Japan
AngeloAntonioIzzo,Italy BeritSmestadPaulsen,Norway KenYasukawa,Japan
StefanieJoos,Germany RichardPietras,USA E.Yesilada,Turkey
Z.Kain,USA KhalidRahman,UK BoliZhang,China
JongYeolKim,RepublicofKorea CheppailRamachandran,USA HongZhang,China
Cheorl-HoKim,RepublicofKorea RuixinZhang,USA
Contents
ThePotentialBenefitofComplementary/AlternativeMedicineinCardiovascularDiseases,Ke-jiChen,
KaKitHui,MyeongSooLee,andHaoXu
Volume2012,ArticleID125029,1page
ImpactofTranscendentalMeditationonLeftVentricularMassinAfricanAmericanAdolescents,
VernonA.Barnes,GastonK.Kapuku,andFrankA.Treiber
Volume2012,ArticleID923153,6pages
ChineseMedicineInjectionQingkailingforTreatmentofAcuteIschemiaStroke:ASystematicReviewof
RandomizedControlledTrials,FafengCheng,XueqianWang,YiLu,XianggenZhong,YanZhao,
andQingguoWang
Volume2012,ArticleID213172,7pages
EffectofKeishibukuryoganonEndothelialFunctioninPatientswithatLeastOneComponentofthe
DiagnosticCriteriaforMetabolicSyndrome:AControlledClinicalTrialwithCrossoverDesign,
YutakaNagata,HirozoGoto,HiroakiHikiami,TatsuyaNogami,MakotoFujimoto,NaotoshiShibahara,
andYutakaShimada
Volume2012,ArticleID359282,10pages
Metabolomics-BasedStudyofClinicalandAnimalPlasmaSamplesinCoronaryHeartDiseasewith
BloodStasisSyndrome,HuihuiZhao,JianxinChen,QiShi,XuelingMa,YiYang,LiangtaoLuo,
ShuzhenGuo,YongWang,JingHan,andWeiWang
Volume2012,ArticleID638723,6pages
TheEffectsofJiang-Zhi-NingandItsMainComponentsonCholesterolMetabolism,JianxinChen,
HuihuiZhao,XuelingMa,XiaoHan,LiangtaoLuo,LuyaWang,JingHan,BingLiu,andWeiWang
Volume2012,ArticleID928234,10pages
KoreanRedGinsengImprovesBloodPressureStabilityinPatientswithIntradialyticHypotension,
I-JuChen,Ming-YangChang,Sheng-LinChiao,Jiun-LiangChen,Chun-ChenYu,Sien-HungYang,
Ju-MeiLiu,Cheng-ChiehHung,Rong-ChiYang,Hui-ChiChang,Chung-HuaHsu,andJi-TsengFang
Volume2012,ArticleID595271,9pages
TheProtectiveEffectofApaminonLPS/Fat-InducedAtheroscleroticMice,Soo-JungKim,Ji-HyunPark,
Kyung-HyunKim,Woo-RamLee,SokCheonPak,Sang-MiHan,andKwan-KyuPark
Volume2012,ArticleID305454,10pages
Lipid-RegulatingEffectofTraditionalChineseMedicine:MechanismsofActions,Wei-JianBei,JiaoGuo,
Hai-YunWu,andYangCao
Volume2012,ArticleID970635,10pages
ChineseMedicineShenfuInjectionforHeartFailure:ASystematicReviewandMeta-Analysis,
SongWen-Ting,ChengFa-Feng,XuLi,LinCheng-Ren,andLiuJian-Xun
Volume2012,ArticleID713149,25pages
TheEffectsofVelvetAntlerofDeeronCardiacFunctionsofRatswithHeartFailurefollowing
MyocardialInfarction,Ming-JingShao,Shuo-RenWang,Ming-JingZhao,Xi-LingLv,HaoXu,LinLi,
HuanGu,Jiu-LiangZhang,GeLi,Xiang-NingCui,andLiHuang
Volume2012,ArticleID825056,5pages
OutcomeMeasuresofChineseHerbalMedicineforCoronaryHeartDisease:AnOverviewofSystematic
Reviews,JingLuoandHaoXu
Volume2012,ArticleID927392,9pages
AquaticExerciseIsEffectiveinImprovingExercisePerformanceinPatientswithHeartFailureandType
2DiabetesMellitus,CiderA˚sa,SchaufelbergerMaria,StibrantSunnerhagenKatharina,andAnderssonBert
Volume2012,ArticleID349209,8pages
AstragalusInjectionforHypertensiveRenalDamage:ASystematicReview,TianSun,HaoXu,
andFengqinXu
Volume2012,ArticleID929025,6pages
ASystematicReviewofXuezhikang,anExtractfromRedYeastRice,forCoronaryHeartDisease
ComplicatedbyDyslipidemia,QinghuaShang,ZhaolanLiu,KejiChen,HaoXu,andJianpingLiu
Volume2012,ArticleID636547,18pages
InSilicoSyndromePredictionforCoronaryArteryDiseaseinTraditionalChineseMedicine,PengLu,
JianxinChen,HuihuiZhao,YiboGao,LiangtaoLuo,XiaohanZuo,QiShi,YipingYang,JianqiangYi,
andWeiWang
Volume2012,ArticleID142584,11pages
Atherosclerosis:AnIntegrativeEast-WestMedicinePerspective,HaoXu,DazhuoShi,andKejiChen
Volume2012,ArticleID148413,4pages
SulfotanshinoneSodiumInjectionforUnstableAnginaPectoris:ASystematicReviewofRandomized
ControlledTrials,XuelanQiu,AndrewMiles,XuehuaJiang,XinSun,andNanYang
Volume2012,ArticleID715790,11pages
NaturalProductNitricOxideChemistry:NewActivityofOldMedicines,HongJiang,
AshleyC.Torregrossa,DeepaK.Parthasarathy,andNathanS.Bryan
Volume2012,ArticleID873210,9pages
TraditionalChineseHerbalProductsforCoronaryHeartDisease:AnOverviewofCochraneReviews,
YuQiu,HaoXu,andDazhuoShi
Volume2012,ArticleID417387,5pages
EthanolicExtractofVitisthunbergiiExhibitsLipidLoweringPropertiesviaModulationofthe
AMPK-ACCPathwayinHypercholesterolemicRabbits,Chun-HsuPan,Chia-HuaTsai,Wen-HsinLin,
Guo-YanChen,andChieh-HsiWu
Volume2012,ArticleID436786,10pages
QiliqiangxinAffectsLTypeCa2+CurrentintheNormalandHypertrophiedRatHeart,YidongWei,
XiaoyuLiu,LeiHou,WenliangChe,ErlindaThe,andMuktanandVikashJhummon
Volume2012,ArticleID131830,4pages
ClinicalandEpidemiologicalInvestigationofTCMSyndromesofPatientswithCoronaryHeartDisease
inChina,YiRen,MinzhouZhang,KejiChen,ShijieYou,JianjunLi,LihengGuo,andLeiWang
Volume2012,ArticleID714517,5pages
AStudyofPrognosis,Outcome,andChangingTendencyofHospitalizedAMIPatientsinBeijing
Third-GradeA-LevelTraditionalChineseMedicineHospitalsfrom1999to2008,Ju-JuShang,HuiShi,
QiZhou,WeiGao,andHong-xuLiu
Volume2012,ArticleID837194,6pages
DesignandMethodsforaPilotStudyofaPhone-Delivered,Mindfulness-BasedInterventioninPatients
withImplantableCardioverterDefibrillators,ElenaSalmoirago-Blotcher,JamesCarmody,GloriaYeh,
SybilCrawford,LawrenceRosenthal,andIraOckene
Volume2012,ArticleID972106,8pages
RefinedQingkailingProtectsMCAOMicefromEndoplasmicReticulumStress-InducedApoptosiswitha
BroadTimeWindow,FafengCheng,XianggenZhong,YiLu,XueqianWang,WentingSong,ShaoyingGuo,
XiaotongWang,DantongLiu,andQingguoWang
Volume2012,ArticleID567872,12pages
CardioprotectiveEffectoftheCompoundYangshenGranuleinRatModelswithAcuteMyocardial
Infarction,XieMing,WangTongshen,WuDelin,andZhaoRonghua
Volume2012,ArticleID717123,6pages
TheEvaluationofChineseTherapeuticFoodfortheTreatmentofModerateDyslipidemia,ShuSun,
HongXu,andLawrenceNgeh
Volume2012,ArticleID508683,10pages
DrugTargetPredictionBasedontheHerbsComponents:TheStudyontheMultitargets
PharmacologicalMechanismofQishenkeliActingontheCoronaryHeartDisease,YongWang,
ZhongyangLiu,ChunLi,DongLi,YulinOuyang,JundaYu,ShuzhenGuo,FuchuHe,andWeiWang
Volume2012,ArticleID698531,10pages
BerberineImprovesInsulinSensitivitybyInhibitingFatStoreandAdjustingAdipokinesProfilein
HumanPreadipocytesandMetabolicSyndromePatients,JingYang,JinhuaYin,HongfeiGao,LinxinXu,
YanWang,LuXu,andMingLi
Volume2012,ArticleID363845,9pages
ChineseHerbandFormulasforPromotingBloodCirculationandRemovingBloodStasisand
AntiplateletTherapies,YueLiu,Hui-JunYin,Da-zhuoShi,andKe-jiChen
Volume2012,ArticleID184503,8pages
SystematicReviewofChineseHerbalMedicinesforPreventingin-StentCoronaryRestenosisafter
PercutaneousCoronaryIntervention,Guo-HuaZheng,Jian-PingLiu,NissiS.Wang,Hai-YingChen,
andJian-FengChu
Volume2012,ArticleID253409,19pages
InVitroAssessmentofCytochromeP4502C19PotentialofNaoxintong,HuiChen,YaZhang,
XiaoyingWu,CandongLi,andHuanWang
Volume2012,ArticleID430262,6pages
TanshinoneIIA:APromisingNaturalCardioprotectiveAgent,QinghuaShang,HaoXu,andLiHuang
Volume2012,ArticleID716459,7pages
ControlStrategyonHypertensioninChineseMedicine,JieWangandXingjiangXiong
Volume2012,ArticleID284847,6pages
HindawiPublishingCorporation
Evidence-BasedComplementaryandAlternativeMedicine
Volume2012,ArticleID125029,1page
doi:10.1155/2012/125029
Editorial
The Potential Benefit of Complementary/Alternative Medicine in
Cardiovascular Diseases
Ke-jiChen,1KaKitHui,2MyeongSooLee,3andHaoXu1
1CardiovascularCenter,XiyuanHospital,ChinaAcademyofChineseMedicalSciences,Beijing100091,China
2CenterforEast-WestMedicine,UniversityofCaliforniaatLosAngeles,SantaMonica,CA90404,USA
3MedicalResearchDivision,KoreaInstituteofOrientalMedicine,Daejeon305-811,RepublicofKorea
CorrespondenceshouldbeaddressedtoKe-jiChen,keji [email protected]
Received6May2012;Accepted6May2012
Copyright©2012Ke-jiChenetal.ThisisanopenaccessarticledistributedundertheCreativeCommonsAttributionLicense,
whichpermitsunrestricteduse,distribution,andreproductioninanymedium,providedtheoriginalworkisproperlycited.
Cardiovascular diseases (CVDs) prevalence continues to Red Yeast Rice, was reviewed in the treatment of coronary
increase,anditisstillthenumberonekillersofar.In2002, heart disease complicated by dyslipidemia. A pharmaco-
nearly17milliondeathsallovertheworldwereattributable logical and mechanistic study showed Naoxintong’s effect
to CVDs, which accounted for almost 30% of the total on cytochrome P450 2C19. Further, one study showed
deaths.Despitetreatmentwithpercutaneouscoronaryinter- the effect of berberine on improving insulin sensitivity
vention (PCI) and many other conventional medicines, by inhibiting fat store and adjusting adipokines profile in
CVDs patients are still confronted with certain risk of re- humanpreadipocytesandmetabolicsyndromepatients.
current acute cardiovascular events, readmission to the Intheauthors’opinion,theclinicalresearchofChinese
hospital, and unfavorable quality of life. In recent years, medicine and other CAMs for CVDs still faces some major
moreandmoreclinicianshavesuccessfullyappliedcomple- challenges. Issues such as overall quality of medical service
mentary/alternative medicine (CAM) in CVDs prevention and the unmet medical needs in the contemporary society
and treatment based on standardized conventional therapy. are common to these medicines. A general guideline is
Nevertheless, the role of CAM in CVDs still needs more required for practicing Chinese medicine and other CAMs,
clinicalevidenceanddefinitemechanismofactions. which should be developed based on solid evidence from
Inthisissue,acollectionofseveraloriginalresearchar- well-designedandwell-executedclinicalstudies.Suchisthe
ticles and reviews are presented that address the clinical direction that the research of Chinese Medicine and other
application and the mechanism of action of CAM in the CAMshouldfollow.
treatmentofCVDs.Theseworksweresubmittedbyresearch-
ers from different parts of the world, including China, Ke-jiChen
KaKitHui
Japan,SouthKorea,Australia,andSweden.Inthesestudies,
the effectiveness of Chinese medicine and some other MyeongSooLee
HaoXu
alternative therapeutic methods in improving symptoms
was demonstrated in patients with hypertension, chronic
stable coronary artery disease, chronic heart failure, and so
forth. Specifically, the use of Chinese herbal medicines was
reviewed for the prevention of in-stent coronary restenosis
afterPCI.ThestudyofTanshinoneIIA,aditerpenequinine
extracted from the root of salvia miltiorrhiza, a Chinese
traditional herb, was presented as a promising cardiopro-
tectiveagent.ThepositiveeffectofChinesefoodandherbal
medicinesinimprovingcertainmoderatedyslipidemiaswas
described. The usefulness of Xuezhikang, an extract from